Literature DB >> 4287844

Factors controlling amino acid incorporation by ribosomes from krebs II mouse ascites-tumour cells.

I M Kerr, N Cohen, T S Work.   

Abstract

1. A ribosome-cell sap system capable of supporting the incorporation of (14)C-labelled amino acids into protein has been prepared from Krebs II mouse ascites-tumour cells. The requirements of this system for optimum activity and response to added messenger RNA have been investigated. One such system has been obtained for which amino acid incorporation is almost wholly dependent on the addition of suitable messenger RNA. 2. Ribosomes of widely different but predictable activities in the cell-free system have been prepared from Krebs cells pretreated in a variety of ways. The factors in the pretreatment of the cells responsible for these differences have been investigated. 3. The structural and functional properties of these different ribosome preparations and their response to exogenous messenger RNA have been examined and are discussed in the light of modern concepts of the control of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4287844      PMCID: PMC1264925          DOI: 10.1042/bj0980826

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  ON THE MECHANISM OF RIBOSOMAL ACTIVATION IN NEWLY FERTILIZED SEA URCHIN EGGS.

Authors:  T HULTIN
Journal:  Dev Biol       Date:  1964-10       Impact factor: 3.582

2.  THE ISOLATION, CHARACTERIZATION AND ACID-BASE PROPERTIES OF RIBONUCLEIC ACID FROM RABBIT-RETICULOCYTE RIBOSOMES.

Authors:  R A COX; H R ARNSTEIN
Journal:  Biochem J       Date:  1963-12       Impact factor: 3.857

3.  The initiation of virus protein synthesis in Krebs ascites tumor cells infected with EMC virus.

Authors:  I M KERR; E M MARTIN; M G HAMILTON; T S WORK
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

4.  Basis of actinomycin action. I. DNA binding and inhibition of RNA-polymerase synthetic reactions by actinomycin.

Authors:  I H GOLDBERG; M RABINOWITZ; E REICH
Journal:  Proc Natl Acad Sci U S A       Date:  1962-12-15       Impact factor: 11.205

5.  The intzraction of infectious ribonucleic acids with mammalian cells. III. Comparison of infection and RNA uptake in the HeLa cell-polio RNA and L cell-mengo RNA systems.

Authors:  K A ELLEM; J S COLTER
Journal:  Virology       Date:  1961-10       Impact factor: 3.616

6.  The role of deoxyribonucleic acid in ribonucleic acid synthesis. III. The inhibition of the enzymatic synthesis of ribonucleic acid and deoxyribonucleic acid by actinomycin D and proflavin.

Authors:  J HURWITZ; J J FURTH; M MALAMY; M ALEXANDER
Journal:  Proc Natl Acad Sci U S A       Date:  1962-07-15       Impact factor: 11.205

7.  Protein synthesis in guinea-pig liver; incorporation of radioactive amino acids into proteins of the microsome fraction in vivo.

Authors:  J L SIMKIN; T S WORK
Journal:  Biochem J       Date:  1957-02       Impact factor: 3.857

8.  The function of high-molecular-weight ribonucleic acid from rabbit reticulocytes in haemoglobin biosynthesis.

Authors:  H R Arnstein; R A Cox; J A Hunt
Journal:  Biochem J       Date:  1964-09       Impact factor: 3.857

9.  Fate of a Synthetic Polynucleotide Directing Cell-Free Protein Synthesis I. Characteristics of Degradation.

Authors:  S H Barondes; M W Nirenberg
Journal:  Science       Date:  1962-11-16       Impact factor: 47.728

10.  Breakdown of rat-liver ergosomes in vivo after actinomycin inhibition of messenger RNA synthesis.

Authors:  T STAEHELIN; F O WETTSTEIN; H NOLL
Journal:  Science       Date:  1963-04-12       Impact factor: 47.728

View more
  25 in total

1.  Interferon-induced inhibition of protein synthesis in L-cell extracts: an ATP-dependent step in the activation of an inhibitor by double-stranded RNA.

Authors:  W K Roberts; M J Clemens; I M Kerr
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

2.  Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells.

Authors:  E Falcoff; R Falcoff; B Lebleu; M Revel
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

3.  In vitro translation of oogenetic messenger RNA of sea urchin eggs and picornavirus RNA with a cell-free system from sarcoma 180.

Authors:  N Jenkins; M W Taylor; R A Raff
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Synthesis of capsid and noncapsid viral proteins in response to encephalomyocarditis virus ribonucleic acid in animal cell-free systems.

Authors:  P Dobos; I M Kerr; E M Martin
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

5.  Characterization of the polypeptides formed in response to encephalomyocarditis virus ribonucleic acid in a cell-free system from mouse ascites tumor cells.

Authors:  I M Kerr; R E Brown; D R Tovell
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

6.  Virus protein synthesis in animal cell-free systems: nature of the products synthesized in resonse to ribonucleic acid of encephalomyocarditis virus.

Authors:  I M Kerr; E M Martin
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

7.  Translation of encephalomyocarditis viral RNA in oocytes of Xenopus laevis.

Authors:  R A Laskey; J B Gurdon; L V Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

8.  Proein-synthetic activity of ribosomes from interferon-treated cells.

Authors:  I M Kerr; E M Martin
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

9.  Role of mammalian RNase inhibitor in cell-free protein synthesis.

Authors:  G Scheele; P Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  Specific changes in the messenger ribonucleic acid content of the rat ventral prostate gland after androgenic stimulation. Evidence from the synthesis of aldolase messenger ribonucleic acid.

Authors:  W I Mainwaring; F R Mangan; R A Irving; D A Jones
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.